Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of May 2019, specifically reporting on a capital increase approved by the Board of Directors on May 2, 2019. The filing details the issuance of new common shares resulting from the exercise of stock options granted in 2009 under the company's Stock Option Plan.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it focuses on capital structure changes:
- Capital Increase Amount: BRL 119,115.39
- New Capital Stock Total: BRL 57,798,963,357.59
- Shares Issued: 272,900 new common shares (no par value)
- Issuance Price: BRL 0.43648 per share
- Potential Dilution: 0.00174%
Material Changes
The primary material change is the increase in authorized capital stock due to the exercise of options by beneficiaries. The filing provides historical market price data for comparison but does not report operational changes or year-over-year financial performance shifts.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to future operations. It is a procedural notice regarding the verification of share issuance and the update of capital stock figures.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to confirm the 0.00174% dilution impact.
- Confirm the exercise price (BRL 0.43648) against the prevailing market price (approx. BRL 17.57 average over 90 days) to assess the value transfer.
- Review the company's 20-F annual report for comprehensive financial statements, as this 6-K does not contain them.
- Check subsequent filings for the final registration of the new shares with the Brazilian Securities and Exchange Commission.